PuSH - Publication Server of Helmholtz Zentrum München

Journal browsing

27 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
1.
Hedskog, C.* et al.: No remdesivir resistance observed in the phase 3 severe and moderate COVID-19 SIMPLE trials. Viruses 16:546 (2024)
2.
Janke, C.* et al.: Understanding the omicron variant impact in healthcare workers: Insights from the prospective COVID-19 post-immunization serological cohort in Munich (KoCo-Impf) on risk factors for breakthrough and reinfections. Viruses 16:1556 (2024)
3.
Kupke, P.* et al.: Cytokine response of natural killer cells to Hepatitis B virus infection depends on monocyte co-stimulation. Viruses 16:741 (2024)
4.
Kallies, R.* ; Hu, D.* ; Abdulkadir, N.* ; Schloter, M. & Rocha, U.*: Identification of huge phages from wastewater metagenomes. Viruses 15:2330 (2023)
5.
Reinkemeyer, C.* et al.: The prospective COVID-19 post-immunization serological cohort in Munich (KoCo-Impf): Risk factors and determinants of immune response in healthcare workers. Viruses 15:25 (2023)
6.
Willy, C.* et al.: Phage therapy in Germany-update 2023. Viruses 15:23 (2023)
7.
Cheng, S.* et al.: Intense innate immune responses and severe metabolic disorders in chicken embryonic visceral tissues caused by infection with highly virulent newcastle disease virus compared to the avirulent virus: A bioinformatics analysis. Viruses 14:911 (2022)
8.
Hufsky, F.* et al.: Women in the European virus bioinformatics center. Viruses 14:1522 (2022)
9.
Liu, H.* et al.: Influenza A virus infection reactivates human endogenous retroviruses associated with modulation of antiviral immunity. Viruses 14:1591 (2022)
10.
Lücke, A.C.* et al.: High-throughput platform for detection of neutralizing antibodies using flavivirus reporter replicon particles. Viruses 14:346 (2022)
11.
Aghaee, B.L.* ; Khan Mirzaei, M. ; Alikhani, M.Y.* ; Mojtahedi, A.* & Maurice, C.F.*: Improving the inhibitory effect of phages against Pseudomonas aeruginosa isolated from a burn patient using a combination of phages and antibiotics. Viruses 13:334 (2021)
12.
Deschler, S.* et al.: Mucosal-associated invariant T (MAIT) cells are highly activated and functionally impaired in COVID-19 patients. Viruses 13:241 (2021)
13.
Durso-Cain, K.* et al.: HCV spread kinetics reveal varying contributions of transmission modes to infection dynamics. Viruses 13:1308 (2021)
14.
Goettsch, W.* et al.: ITN-VIROINF: Understanding (Harmful) virus-host interactions by linking virology and bioinformatics. Viruses 13:766 (2021)
15.
Rahman, M.* et al.: Differential effect of SARS-CoV-2 spike glycoprotein 1 on human bronchial and alveolar lung mucosa models: Implications for pathogenicity. Viruses 13:2537 (2021)
16.
Wettengel, J.M. et al.: Rapid and robust continuous purification of high-titer hepatitis B virus for in vitro and in vivo applications. Viruses 13:1503 (2021)
17.
Velkov, S.* ; Protzer, U. & Michler, T.: Global occurrence of clinically relevant hepatitis B virus variants as found by analysis of publicly available sequencing data. Viruses 12:1344 (2020)
18.
Wettengel, J.M. & Burwitz, B.J.*: Innovative HBV animal models based on the entry receptor NTCP. Viruses 12:828 (2020)
19.
Fei, Y.* et al.: The emergence of avian orthoavulavirus 13 in wild migratory waterfowl in China revealed the existence of diversified trailer region sequences and HN gene lengths within this serotype. Viruses 11:646 (2019)
20.
Conzade, R. et al.: Reported direct and indirect contact with dromedary camels among laboratory-confirmed MERS-CoV cases . Viruses 10:425 (2018)